Tag: efficacy

ProNAi Therapeutics (NASDAQ:DNAI) On August 12, 2016 ProNAi Therapeutics had finally completely dropped its PNT2258 drug from its pipeline. It has been a long tough...

Seres Therapeutics (NASDAQ:MCRB) On Friday, Seres Therapeutics stock plummeted by 70% after the company reported that it had failed mid-stage trial in patients with Clostridium...

StemCells Inc. (NASDAQ:STEM) On Tuesday May 31, 2016 shares of Stemcells fell by more than 83% after the company announced that it would completely stop...

Rxi Pharmaceuticals (NASDAQ:RXII) On Tuesday April 19, 2016 Rxi Pharmaceuticals announced that it would present pre-clinical data at a medical conference, known as 2016 ARVO...

BioCryst Pharmaceuticals (NASDAQ: BCRX) On February 8, 2016 shares of BioCryst Pharmaceuticals fell by more than 71% after the company had announced that it had...

Amgen, Inc. (NASDAQ:AMGN) On October 28, 2015 Amgen had announced that it had received FDA approval for its skin cancer drug known as IMLYGIC. This...

Bluebird Bio (NASDAQ:BLUE)  On October 19, 2015 shares of Bluebird Bio fell approximately 4% after the company announced that one patient on its old generation...

Immunogen (NASDAQ:IMGN) Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian...